Helix BioPharma Corp. (HBP) — Working Capital to Net Assets Ratio
Helix BioPharma Corp. (HBP) has a Working Capital to Net Assets ratio of -19.7% as of January 2026. Working capital of CA$-3.03 Million (current assets of CA$135.00K minus current liabilities of CA$3.16 Million) is measured against net assets of CA$15.36 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Helix BioPharma Corp. (HBP) financial flexibility to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Helix BioPharma Corp. Working Capital to Net Assets (2007–2025)
This chart shows how Helix BioPharma Corp.'s Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of January 2026, the ratio stands at -19.7%, reflecting working capital of CA$-3.03 Million against net assets of CA$15.36 Million CAD. See Helix BioPharma Corp. liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Helix BioPharma Corp. (2007–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Helix BioPharma Corp. from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see HBP stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (CAD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -18.0% | CA$-2.81 Million | CA$15.59 Million | CA$409.00K | CA$3.22 Million | ▼ -154.7 pp |
| 2024 | 136.7% | CA$-123.00K | CA$-90.00K | CA$1.46 Million | CA$1.58 Million | ▲ +32.6 pp |
| 2023 | 104.0% | CA$-878.00K | CA$-844.00K | CA$996.00K | CA$1.87 Million | ▲ +15.0 pp |
| 2022 | 89.0% | CA$284.00K | CA$319.00K | CA$3.69 Million | CA$3.41 Million | ▲ +99.4 pp |
| 2021 | -10.3% | CA$144.00K | CA$-1.39 Million | CA$4.02 Million | CA$3.87 Million | ▼ -102.1 pp |
| 2020 | 91.7% | CA$2.73 Million | CA$2.98 Million | CA$4.66 Million | CA$1.93 Million | ▼ -16.0 pp |
| 2019 | 107.7% | CA$-3.53 Million | CA$-3.28 Million | CA$687.00K | CA$4.22 Million | ▼ -16.8 pp |
| 2018 | 124.5% | CA$-1.90 Million | CA$-1.53 Million | CA$773.00K | CA$2.67 Million | ▼ -2840.2 pp |
| 2017 | 2964.7% | CA$-504.00K | CA$-17.00K | CA$1.70 Million | CA$2.20 Million | ▲ +2872.1 pp |
| 2016 | 92.6% | CA$2.93 Million | CA$3.16 Million | CA$4.23 Million | CA$1.30 Million | ▼ -2.6 pp |
| 2015 | 95.2% | CA$6.50 Million | CA$6.83 Million | CA$7.47 Million | CA$969.00K | ▲ +1.8 pp |
| 2014 | 93.4% | CA$6.36 Million | CA$6.81 Million | CA$7.41 Million | CA$1.04 Million | ▲ +7.2 pp |
| 2013 | 86.2% | CA$4.24 Million | CA$4.92 Million | CA$5.19 Million | CA$948.00K | ▲ +9.9 pp |
| 2012 | 76.4% | CA$4.75 Million | CA$6.22 Million | CA$6.12 Million | CA$1.37 Million | ▼ -11.7 pp |
| 2011 | 88.0% | CA$19.47 Million | CA$22.11 Million | CA$21.68 Million | CA$2.21 Million | ▲ +3.1 pp |
| 2010 | 84.9% | CA$13.39 Million | CA$15.76 Million | CA$15.67 Million | CA$2.28 Million | ▼ -4.7 pp |
| 2009 | 89.6% | CA$15.30 Million | CA$17.06 Million | CA$17.45 Million | CA$2.16 Million | ▼ -3.7 pp |
| 2008 | 93.4% | CA$19.17 Million | CA$20.52 Million | CA$20.31 Million | CA$1.14 Million | ▲ +3.3 pp |
| 2007 | 90.1% | CA$11.47 Million | CA$12.73 Million | CA$13.01 Million | CA$1.54 Million | — |